Indivior Gross Profit 2012-2025 | INDV

Indivior gross profit from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Indivior Annual Gross Profit
(Millions of US $)
2024 $957
2023 $919
2022 $742
2021 $664
2020 $550
2019 $645
2018 $877
2017 $989
2016 $951
2015 $917
2014 $1,020
2013 $1,112
2012 $1,245
2011 $1,173
Indivior Quarterly Gross Profit
(Millions of US $)
2025-09-30 $231
2025-06-30 $250
2025-03-31 $222
2024-12-31 $250
2024-09-30 $241
2024-06-30 $220
2024-03-31 $246
2023-12-31 $254
2023-09-30 $225
2023-06-30 $226
2023-03-31 $214
2022-12-31 $197
2022-09-30 $192
2022-06-30 $183
2022-03-31 $170
2021-12-31 $184
2021-09-30 $161
2021-06-30 $171
2021-03-31 $148
2020-12-31 $162
2020-09-30 $126
2020-06-30 $132
2020-03-31 $130
2019-12-31 $91
2019-09-30 $165
2019-06-30 $188
2019-03-31 $201
2018-12-31 $203
2018-09-30 $210
2018-06-30 $233
2018-03-31 $231
2017-12-31 $232
2017-09-30 $248
2017-06-30 $263
2017-03-31 $246
2016-12-31 $230
2016-09-30 $243
2016-06-30 $241
2016-03-31 $237
2015-12-31 $223
2015-09-30 $225
2015-06-30 $242
2015-03-31 $227
2014-12-31
2014-09-30 $245
2014-06-30 $267
2013-12-31
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $1.188B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.450B 33.97
Zoetis (ZTS) United States $52.293B 18.72
Takeda Pharmaceutical (TAK) Japan $45.598B 9.31
Daiichi Sankyo, - (DSNKY) Japan $40.539B 20.19
BeOne Medicines - (ONC) Switzerland $37.820B 185.50
Sandoz Group AG (SDZNY) Switzerland $31.838B 0.00
United Therapeutics (UTHR) United States $21.270B 18.72
Merck (MKKGY) Germany $17.881B 11.02
Neurocrine Biosciences (NBIX) United States $15.235B 36.56
Shionogi (SGIOY) Japan $14.445B 13.27
Summit Therapeutics (SMMT) United States $13.549B 0.00
Ionis Pharmaceuticals (IONS) United States $13.091B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.978B 0.00
IPSEN (IPSEY) France $11.918B 0.00
Orion OYJ (ORINY) Finland $9.738B 27.82
Corcept Therapeutics (CORT) United States $9.256B 99.99
Eisai (ESAIY) $8.400B 0.00
Stevanato Group S.p.A (STVN) Italy $6.305B 35.29
Grifols, S.A (GRFS) Spain $6.284B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.238B 18.97
Crinetics Pharmaceuticals (CRNX) United States $4.791B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.544B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.224B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.838B 18.22
Centessa Pharmaceuticals (CNTA) United Kingdom $3.564B 0.00
Ocular Therapeutix (OCUL) United States $3.102B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.903B 9.26
Soleno Therapeutics (SLNO) United States $2.793B 0.00
Dyne Therapeutics (DYN) United States $2.752B 0.00
Hypermarcas (HYPMY) Brazil $2.737B 18.79
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.090B 24.77
Avadel Pharmaceuticals (AVDL) Ireland $2.086B 0.00
Guardian Pharmacy Services (GRDN) United States $1.911B 36.81
Harrow (HROW) United States $1.743B 106.96
BioCryst Pharmaceuticals (BCRX) United States $1.594B 94.62
Collegium Pharmaceutical (COLL) United States $1.537B 7.61
Ardelyx (ARDX) United States $1.509B 0.00
Oruka Therapeutics (ORKA) United States $1.461B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.439B 0.00
Savara (SVRA) United States $1.408B 0.00
Relay Therapeutics (RLAY) United States $1.392B 0.00
Cronos Group (CRON) Canada $1.250B 0.00
Xeris Biopharma Holdings (XERS) United States $1.190B 0.00
Xencor (XNCR) United States $1.180B 0.00
Nektar Therapeutics (NKTR) United States $1.113B 0.00
Evotec AG (EVO) Germany $1.069B 0.00
ARS Pharmaceuticals (SPRY) United States $1.012B 0.00
Enliven Therapeutics (ELVN) United States $1.001B 0.00
Theravance Biopharma (TBPH) United States $0.921B 38.66
Esperion Therapeutics (ESPR) United States $0.920B 0.00
KalVista Pharmaceuticals (KALV) United States $0.855B 0.00
Aquestive Therapeutics (AQST) United States $0.758B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.740B 6.61
Lyell Immunopharma (LYEL) United States $0.732B 0.00
Lexeo Therapeutics (LXEO) United States $0.713B 0.00
ProKidney (PROK) United States $0.665B 0.00
Bioventus (BVS) United States $0.625B 12.80
4D Molecular Therapeutics (FDMT) United States $0.619B 0.00
Organogenesis (ORGO) United States $0.612B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.582B 13.77
Altimmune (ALT) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.469B 0.00
Siga Technologies (SIGA) United States $0.463B 6.33
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Galectin Therapeutics (GALT) United States $0.403B 0.00
Nature's Sunshine Products (NATR) United States $0.398B 23.69
USANA Health Sciences (USNA) United States $0.373B 10.42
Aclaris Therapeutics (ACRS) United States $0.352B 0.00
Avalo Therapeutics (AVTX) United States $0.337B 0.00
Larimar Therapeutics (LRMR) United States $0.335B 0.00
OmniAb (OABI) United States $0.310B 0.00
Fractyl Health (GUTS) United States $0.307B 0.00
Silence Therapeutics (SLN) United Kingdom $0.299B 0.00
Relmada Therapeutics (RLMD) United States $0.298B 0.00
Protara Therapeutics (TARA) United States $0.294B 0.00
Aldeyra Therapeutics (ALDX) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.247B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.227B 0.00
Profound Medical (PROF) Canada $0.221B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Surrozen (SRZN) United States $0.211B 0.00
Journey Medical (DERM) United States $0.208B 0.00
AleAnna (ANNA) United States $0.196B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.170B 0.00
China SXT Pharmaceuticals (SXTC) China $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.160B 0.00
Gain Therapeutics (GANX) United States $0.159B 0.00
Incannex Healthcare (IXHL) Australia $0.146B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
Inhibikase Therapeutics (IKT) United States $0.116B 0.00
Prelude Therapeutics (PRLD) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Avita Medical (RCEL) United States $0.106B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Context Therapeutics (CNTX) United States $0.096B 0.00
Plus Therapeutics (PSTV) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.60
VAXART, INC (VXRT) United States $0.089B 0.00
Acrivon Therapeutics (ACRV) United States $0.080B 0.00
Korro Bio (KRRO) United States $0.078B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.065B 0.00
Lite Strategy (LITS) United States $0.063B 0.00
PolyPid (PYPD) Israel $0.062B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Arch Biopartners (ACHFF) Canada $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
BioNxt Solutions (BNXTF) Canada $0.057B 0.00
Talphera (TLPH) United States $0.055B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.038B 31.62
Mural Oncology (MURA) Ireland $0.035B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Klotho Neurosciences (KLTO) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Inotiv (NOTV) United States $0.026B 0.00
Vyome Holdings (HIND) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Liminatus Pharma (LIMN) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Traws Pharma (TRAW) United States $0.019B 0.02
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Tempest Therapeutics (TPST) United States $0.015B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Alaunos Therapeutics (TCRT) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
ProPhase Labs (PRPH) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00